Press Releases

// Jan 08, 2021

ElevateBio to Present at the 39th Annual J.P. Morgan Healthcare Conference

// Jan 08, 2021

ElevateBio to Present at the Piper Sandler 32nd Annual Virtual Healthcare Conference

// Dec 06, 2020

ElevateBio’s HighPassBio Presents on Novel T Cell Receptor Cell Therapy for Leukemia Relapse at 62nd Annual ASH Meeting

// Nov 30, 2020

Piper Sandler 32nd Annual Virtual Healthcare Conference

// Nov 16, 2020

ElevateBio and AgBiome Announce LifeEDIT Will Join ElevateBio’s Portfolio of Innovative Cell and Gene Therapy Companies

// Oct 28, 2020

Morgan Stanley 18th Annual Global Healthcare Conference

// Aug 25, 2020

ElevateBio to Present at the Morgan Stanley 18th Annual Global Healthcare Conference

// May 26, 2020

ElevateBio to Present at the Jefferies Virtual Healthcare Conference

// Mar 30, 2020

ElevateBio Closes $170 Million Series B Financing

// Mar 26, 2020

European Medicines Agency Grants Orphan Drug Designation to AlloVir’s Viralym-M, an Allogeneic, Off-the-Shelf, Multi-Virus Specific T-Cell Therapy

// Mar 23, 2020

AlloVir Expands Its Research Collaboration with Baylor College of Medicine to Discover and Develop Allogeneic, Off-the-Shelf, Virus-Specific T-Cell Therapies for COVID-19

// Mar 05, 2020

ElevateBio Appoints Kareem Reda as Chief Business Officer